In this issue:
Biomarkers for immunotherapy
PS and immunotherapy outcomes
Immunotherapy and large-cell neuroendocrine tumours
Toxicity with chemoimmunotherapy
SCLC outcomes: update of IMpower133
COVID-19: effects on cancer diagnosis and service access
Metformin and lung cancer survival
Lung nodule diagnostic evaluations and outcomes
Symptomatic MPE: risk factors for recurrence
Artificial intelligence in diagnostic radiology
Please login below to download this issue (PDF)